Amalgamated Bank’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,498
Closed -$4K 2715
2025
Q4
$4K Sell
1,498
-184
-11% -$799 ﹤0.01% 2815
2025
Q3
$11K Hold
1,682
﹤0.01% 2436
2025
Q2
$10K Hold
1,682
﹤0.01% 2448
2025
Q1
$14K Buy
1,682
+141
+9% +$1.27K ﹤0.01% 2233
2024
Q4
$11K Hold
1,541
﹤0.01% 2405
2024
Q3
$9K Hold
1,541
﹤0.01% 2524
2024
Q2
$10K Hold
1,541
﹤0.01% 2469
2024
Q1
$20K Sell
1,541
-4,877
-76% -$65K ﹤0.01% 2132
2023
Q4
$82K Sell
6,418
-458
-7% -$4.63K ﹤0.01% 2064
2023
Q3
$90K Buy
6,876
+482
+8% +$8.82K ﹤0.01% 2038
2023
Q2
$164K Buy
6,394
+1,401
+28% +$36.2K ﹤0.01% 1892
2023
Q1
$126K Sell
4,993
-374
-7% -$8.78K ﹤0.01% 1964
2022
Q4
$123K Hold
5,367
﹤0.01% 2052
2022
Q3
$118K Buy
5,367
+82
+2% +$1.59K ﹤0.01% 2074
2022
Q2
$76K Buy
5,285
+387
+8% +$6.52K ﹤0.01% 2290
2022
Q1
$93K Buy
+4,898
New +$95.2K ﹤0.01% 2224

Other funds holding TMCI

Amalgamated Bank's TMCI Position: Q1 2026 in Review

Amalgamated Bank sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 1,498 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in TMCI in Q1 2022 and held it in 16 quarters. The position peaked at $164K in Q2 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Amalgamated Bank reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,498 Treace Medical Concepts shares in Q1 2026, an estimated $4K.
  • Amalgamated Bank first reported a position in Treace Medical Concepts in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Treace Medical Concepts position peaked at $164K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.